Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 18, 2018 - Issue 3
Submit an article Journal homepage
854
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Cost-effectiveness analysis of infliximab, adalimumab, golimumab and vedolizumab for moderate to severe ulcerative colitis in Spain

Cristina Trigo-VicenteDepartment of Pharmacy, Hospital Universitario Miguel Servet, Zaragoza, Spain;Faculty of Pharmacy, University of San Jorge, Zaragoza, SpainCorrespondence[email protected]
View further author information
,
Vicente Gimeno-BallesterDepartment of Pharmacy, Hospital Universitario Miguel Servet, Zaragoza, SpainView further author information
,
Raquel Montoiro-AlluéDepartment of Intensive Care, Hospital Clínico Universitario Lozano Blesa, Zaragoza, SpainView further author information
&
Alejandro López-Del ValDean of Health Science Faculty, University of San Jorge, Zaragoza, SpainView further author information
Pages 321-329 | Received 10 Sep 2017, Accepted 27 Nov 2017, Published online: 02 Dec 2017

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Noritaka Takatsu, Takashi Hisabe, Daijiro Higashi, Toshiharu Ueki & Toshiyuki Matsui. (2020) Vedolizumab in the Treatment of Ulcerative Colitis: An Evidence-Based Review of Safety, Efficacy, and Place of Therapy. Core Evidence 15, pages 7-20.
Read now

Articles from other publishers (7)

Yoram Bouhnik, Raja Atreya, Daniel Casey, Michał Górecki, Deborah Baik, Sang Wook Yoon, Taek Sang Kwon & Minyoung Jang. (2023) Cost-effectiveness Analysis of Subcutaneous Infliximab for Inflammatory Bowel Diseases in Sequential Biologic Treatment. Inflammatory Bowel Diseases 29:6, pages 898-913.
Crossref
Naazish S. Bashir, Avery Hughes & Wendy J. Ungar. (2023) Infliximab Pricing in International Economic Evaluations in Inflammatory Bowel Disease to Inform Biologic and Biosimilar Access Policies: A Systematic Review. MDM Policy & Practice 8:1.
Crossref
Qiong Hu, Xing-zhou Tang, Fang Liu, De-wu Liu & Bo Cao. (2023) Vedolizumab subcutaneous formulation maintenance therapy for patients with IBD: a systematic review and meta-analysis. Therapeutic Advances in Gastroenterology 16, pages 175628482311662.
Crossref
Xueqi Wang, Qiubo Li, Shijiang Sun, Xi Liang, Huijing Li, Jing Huang, Tianhe Zhao, Jingnan Hu, Jianxin Liu, Zhenbiao Hu, Yangyang Duan & Jianming He. (2022) Network meta-analysis and cost-effectiveness analysis of infliximab, cyclosporine and tacrolimus for ulcerative colitis. Medicine 101:51, pages e31850.
Crossref
Elisabetta Fenu, Vasily Lukyanov, Annabel Acs, Xenia Radu, Stephanie Stypa, Aren Fischer, John K. Marshall & Mark Oppe. (2022) Cost Effectiveness of Subcutaneous Vedolizumab for Maintenance Treatment of Ulcerative Colitis in Canada. PharmacoEconomics - Open 6:4, pages 519-537.
Crossref
Bob G SchultzIbrahim DiakiteJohn A CarterSonya J SnedecorRobin Turpin. (2021) Cost-effectiveness of intravenous vedolizumab vs subcutaneous adalimumab for moderately to severely active ulcerative colitis. Journal of Managed Care & Specialty Pharmacy 27:11, pages 1592-1600.
Crossref
Luis Hernandez, Hiroyo Kuwabara, Anshul Shah, Kaoru Yamabe, Heather Burnett, Kyle Fahrbach, Maria Koufopoulou & Ryuichi Iwakiri. (2019) Cost-Effectiveness Analysis of Vedolizumab Compared with Other Biologics in Anti-TNF-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan. PharmacoEconomics 38:1, pages 69-84.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.